Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

VitaNova Life Sciences (YJGJ) Change in Cash (2017 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Change in Cash for 8 consecutive years, with $212661.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash rose 162.03% year-over-year to $212661.0, compared with a TTM value of $1.0 million through Oct 2025, up 365.22%, and an annual FY2025 reading of $189774.0, down 67.52% over the prior year.
  • Change in Cash was $212661.0 for Q4 2025 at VitaNova Life Sciences, down from $263810.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $808356.0 in Q1 2024 and bottomed at -$451401.0 in Q3 2024.
  • Average Change in Cash over 5 years is $78705.1, with a median of $6043.5 recorded in 2022.
  • Peak annual rise in Change in Cash hit 3443.49% in 2024, while the deepest fall reached 9323.19% in 2024.
  • Year by year, Change in Cash stood at $31693.0 in 2021, then plummeted by 83.26% to $5306.0 in 2022, then plummeted by 264.49% to -$8728.0 in 2023, then soared by 1029.88% to $81160.0 in 2024, then soared by 162.03% to $212661.0 in 2025.
  • Business Quant data shows Change in Cash for YJGJ at $212661.0 in Q4 2025, $263810.0 in Q3 2025, and $377637.0 in Q2 2025.